Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
startups
acute myeloid leukemia
adverum biotechnologies
ajay royan
ambit biosciences
athena countouriotis
brett zbar
bristol-myers squibb
cormorant asset management
daiichi sankyo
events
frederic moll
halozyme therapeutics
hbm healthcare investments
hbm partners
health
jean cui
johnson & johnson
life sciences
lilly asia ventures
national blog main
national top stories
nextech invest
orbimed advisors
peter li
pfizer
quizartinib
repotrectinib
robert adelman
san diego
san diego blog main
san diego top stories
san francisco blog main
sandiegovc
sr one
sv tech ventures
tc
techcrunch disrupt sf 2019
tp therapeutics
What
ceo
medical
old
2
×
year
ajay
athena
auris
billion
biotech
cancer
chief
come
company
countouriotis
disrupt
drug
entrepreneurs
financing
frederic
gets
hansen
household
include
intuitive
inventors
investor
j
lead
manufacturer
mezzanine
million
moll
moll’s
names
new
officer
promoted
publicly
push
raised
Language
Current search:
old
×
biotech
×
@techcrunch.com
4 years ago
After selling Auris for $3.4 billion to J&J, CEO Frederic Moll and lead investor Ajay Royan come to Disrupt
@xconomy.com
5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
